Extending recombinant factor IX Fc fusion protein dosing interval to 14 or more days in patients with hemophilia B

Autor: Shapiro, Amy D., Pasi, K. John, Ozelo, Margareth C., Kulkarni, Roshni, Barnowski, Christopher, Winding, Bent, Szamosi, Johan, Lethagen, Stefan *
Zdroj: In Research and Practice in Thrombosis and Haemostasis January 2019 3(1):109-113
Databáze: ScienceDirect
Externí odkaz: